BP update from yesterday
"Earnings revisions Following the 1H17 result we have downgraded our underlying Cash EPS by -16.2%, -8.4% and -4.0% for FY17, FY18 and FY19 respectively. The earnings revision is primarily driven by a purposeful step up in the cost base to support extra sales and other support staff to accelerate the growth in the business. The downgrade is partially offset by the higher growth rates we’ve included in our estimates. Following the earnings revision, our revised Price Target is $0.75 per share (previously $0.77 per share). Our Buy recommendation remains unchanged."
- Forums
- ASX - By Stock
- Ann: Praemium reports record half-year profit
BP update from yesterday "Earnings revisions Following the 1H17...
-
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PPS (ASX) to my watchlist
(20min delay)
|
|||||
Last
66.5¢ |
Change
0.005(0.76%) |
Mkt cap ! $250.6M |
Open | High | Low | Value | Volume |
67.0¢ | 67.0¢ | 65.5¢ | $184.6K | 279.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3498 | 65.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
66.5¢ | 3270 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 7000 | 0.590 |
1 | 52000 | 0.575 |
6 | 111190 | 0.570 |
2 | 35080 | 0.565 |
5 | 50580 | 0.560 |
Price($) | Vol. | No. |
---|---|---|
0.600 | 131318 | 9 |
0.605 | 48960 | 3 |
0.610 | 44045 | 4 |
0.615 | 78993 | 6 |
0.620 | 110891 | 5 |
Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
Featured News
PPS (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online